CCSD code 0527C: Flavivirus IgG antibody test billing guide

Key Takeaways

CCSD code 0527C is a Chapter 34 (Pathology) code in the UK CCSD schedule, used to bill the Flavivirus immunoglobulin G (IgG) antibody test – a serology test covering dengue, Zika, yellow fever, West Nile virus, tick-borne encephalitis, and Japanese encephalitis

A positive IgG result shows past exposure to a flavivirus, not necessarily a recent infection – flaviviruses share antibody targets, so a single IgG sample can rarely confirm which specific virus caused the infection

The trailing letter C in the CCSD schedule’s specimen convention denotes cerebrospinal fluid, meaning 0527C represents the CSF-based version of the assay, most relevant when investigating suspected flavivirus neuroinvasive disease. Always confirm the current specimen and description at ccsd.org.uk

Pabau supports UK private practices with claims management and digital patient records, helping practices apply CCSD codes accurately at the point of invoicing

CCSD code 0527C is the Chapter 34 (Pathology) billing code in the UK CCSD schedule for the Flavivirus IgG (immunoglobulin G) antibody test, a serology panel covering dengue, Zika, yellow fever, West Nile virus, tick-borne encephalitis, and Japanese encephalitis. The schedule is maintained by the Clinical Coding and Schedule Development Group and governs private medical billing across the UK.

A positive result on this code confirms exposure to the flavivirus family, but it rarely says which specific virus caused the infection or whether the infection was recent, since these viruses share antibody targets. This guide covers what the test detects, how to interpret the result, which insurers accept the code, and how to submit a clean claim.

CCSD code 0527C: Official description and what it covers

CCSD code 0527C is a pathology code within the CCSD Diagnostic Schedule, used for private medical billing of the Flavivirus IgG antibody test.

Pathology codes in the CCSD schedule follow a different structure from surgical procedure codes: They map to the NHS National Laboratory Medicine Catalogue, with a four-digit numeric stem followed by a letter that identifies the specimen type, the same convention used by codes like 0081H and 0049C.

The trailing C denotes cerebrospinal fluid (CSF), which fits how this test is most often requested. It runs alongside a blood sample, but specifically looks for antibody production within the central nervous system when a flavivirus infection is suspected of causing meningitis or encephalitis.

The CCSD schedule is updated annually by the Clinical Coding and Schedule Development Group, so always verify the current description, chapter placement, and specimen convention for CCSD code 0527C directly at ccsd.org.uk before submitting a claim.

Practices new to CCSD billing, or that have recently moved from NHS tariff work to Bupa CCSD codes and other insurer schedules, will find the CCSD technical guide useful for understanding how pathology chapters, specimen letters, and bundling rules operate across the full schedule.

For the precise procedure description and any notes attached to this code, consult the CCSD technical guide (October 2025 edition). This is the authoritative source for bundling rules and specimen requirements.

What the flavivirus IgG antibody test detects

Flavivirus is a genus within the Flaviviridae family that includes more than 70 viruses, among them dengue, Zika, yellow fever, West Nile virus, tick-borne encephalitis virus, and Japanese encephalitis virus. Following infection, the immune system produces IgM and IgG antibodies directed mainly against the viral envelope (E) protein, the structure the virus uses to attach to and enter human cells.

The test itself is typically run as an IgG antibody capture ELISA. The timing of the result matters:

• IgM appears first and generally signals a recent infection, within about a month of exposure.
• IgG typically becomes detectable within one to three weeks of infection – roughly a week for dengue, and up to about three weeks for West Nile virus – then persists for years afterward. IgG can be detected shortly after IgM rather than following it by months, and it remains present long after the acute illness has resolved.
• IgG alone, without IgM, typically points to a historic infection rather than a current one.

That persistence is what makes the test useful for confirming past exposure, but it is also the reason a single IgG result needs careful interpretation before it becomes the basis of a diagnosis.

Interpreting flavivirus IgG results: Cross-reactivity and confirmatory testing

The biggest limitation of flavivirus IgG serology is cross-reactivity. Because flaviviruses share a similar envelope protein structure, antibodies raised against one virus frequently bind to others in the same family.

According to the CDC, dengue IgG and IgM results can be difficult to interpret precisely because of cross-reactivity with Zika and West Nile virus antibodies. A positive result on CCSD code 0527C confirms flavivirus exposure, but it does not by itself confirm which flavivirus was responsible.

• Single-sample IgG is not diagnostic on its own. A person with a secondary flavivirus infection may already carry IgG from a prior exposure, and cross-reactive antibodies from a different flavivirus (or a prior yellow fever, Japanese encephalitis, or tick-borne encephalitis vaccination) can produce a positive result.
• Paired samples support a recent-infection diagnosis. Seroconversion – a change from IgG-negative to IgG-positive across two samples taken at least 14 days apart – or a fourfold or greater rise in titer between samples, is the more reliable indicator of a recent infection than a single result.
• Neutralization testing is the confirmatory step. The plaque reduction neutralization test (PRNT) is considered the reference standard for distinguishing which specific flavivirus caused an antibody response. It is labor-intensive and requires a biosafety level 3 laboratory, which is why it is reserved for cases where the specific virus needs to be confirmed.
• Infection versus vaccination can sometimes be distinguished. Antibodies from natural infection tend to include non-structural viral proteins as targets, while vaccine-induced antibodies are typically limited to structural proteins – a distinction that matters for travelers who have been vaccinated against yellow fever, Japanese encephalitis, or tick-borne encephalitis before a trip.

This is also where the CSF specimen matters clinically. Detecting flavivirus IgG in cerebrospinal fluid, rather than blood alone, supports a diagnosis of neuroinvasive disease, such as West Nile virus encephalitis, tick-borne encephalitis, or Japanese encephalitis, because it points to antibody production within the central nervous system rather than antibodies that have simply crossed over from the bloodstream.

Clinicians requesting CCSD code 0527C should document the specimen source clearly, since insurers cross-reference the billed specimen letter against the laboratory report.

Which UK insurers accept CCSD code 0527C?

All major UK private health insurers recognize the CCSD schedule as the basis for private medical billing.

Whether a specific insurer pays for CCSD code 0527C depends on the patient’s policy benefit, whether pre-authorization was obtained, and whether the referral documents a clinical reason for testing, such as recent travel to a flavivirus-endemic region or a suspected neurological infection.

Because this is a specialist infectious-disease test rather than a routine blood panel, obtain written pre-authorization before the sample is taken wherever a patient’s policy requires it. Claiming for CCSD code 0527C without pre-authorization on a policy that requires it is a common cause of a rejected invoice.

CCSD code 0527C fee and reimbursement guidance

There is no single fixed fee for CCSD code 0527C across the private market. Each insurer sets its own reimbursement rate for pathology codes, and rates typically differ from the fee for the equivalent blood-specimen version of the same antibody test.

Fee schedules are published or looked up through each insurer’s own portal, and rates are reviewed on an annual cycle alongside the rest of the CCSD schedule.

How to submit a claim using CCSD code 0527C

Submitting a clean claim for CCSD code 0527C follows the same general Healthcode workflow as any other CCSD pathology code, with a couple of extra checks specific to a flavivirus serology request:

1. Confirm pre-authorization with the insurer, where the patient’s policy requires it for pathology testing.
2. Record the clinical indication – typically recent travel history, presenting symptoms, or a suspected neuroinvasive infection – in the patient’s notes.
3. Verify the specimen matches the code. CCSD code 0527C is the CSF-based version of the test; if the sample sent to the laboratory was blood, the corresponding blood-specimen code should be used instead.
4. Raise the invoice with CCSD code 0527C, the requesting practitioner’s details, and the authorization reference number.
5. Submit the claim via Healthcode or the insurer’s direct billing portal.
6. Track the claim and reconcile any query quickly, since serology requests are commonly queried if the specimen type or clinical indication is unclear on the invoice.

Manage CCSD billing inside your practice software

Pabau helps UK private practices keep patient records, invoices, and CCSD claim documentation in one place – so every serology request is supported by the clinical notes an insurer needs.

Book a demo

Common billing errors with CCSD code 0527C

Because this code has a blood-specimen counterpart and covers a test with a genuinely nuanced clinical interpretation, a handful of billing errors come up more often than with a routine blood panel:

• Specimen mismatch: Billing the CSF-specimen code (0527C) when the sample tested was blood, or vice versa. The billed code must match the laboratory report exactly.
• Missing clinical indication: Submitting the claim without documenting travel history or the suspected neurological presentation that justified the test, which insurers may ask for on audit.
• Missing authorization: Submitting a claim without a valid pre-authorization reference where the policy requires one for pathology testing.
• Treating a single IgG result as diagnostic on the invoice narrative: Documentation that states a definitive diagnosis from one IgG sample, without noting the need for paired samples or confirmatory testing, can draw insurer queries when the clinical picture does not match.
• Confusing IgG and IgM billing: The IgG and IgM antibody tests are separate CCSD codes; billing one when the laboratory ran the other is a straightforward denial trigger.
• Stale fee assumptions: Using a rate from a previous year’s insurer fee schedule instead of checking the current one.

Related CCSD pathology codes

CCSD pathology codes are organized by chapter, with related tests often sharing a numeric stem but differing by specimen letter or by the specific antibody class detected. Selecting the wrong code from a related cluster, or billing the wrong specimen letter, is one of the most common private billing errors for infectious disease serology.

Practices billing 0527C often handle other Chapter 34 virology codes in the same billing cycle, including 0309O, where the same specimen-matching discipline applies.

The CCSD schedule at ccsd.org.uk is the definitive source for confirming the exact code numbers, descriptors, and specimen letters in force for these related pathology tests, since exact numbering can change between schedule editions.

Managing CCSD code 0527C billing in Pabau

Private practices billing pathology codes like CCSD code 0527C juggle several moving pieces: The referral, the lab request with its specimen type, the invoice, and the Healthcode submission often live in separate systems, and a mismatch between any two of them is what triggers an insurer query.

Practice management software like Pabau brings these pieces together in one place.

Pabau’s claims management software lets practices raise invoices directly from the clinical record, so the specimen type and clinical indication documented in the patient note match the code submitted on the claim.

Practices working with GP clinic software or travel clinic software in the UK private sector get the same alignment between the lab request and the billing record, which is what keeps query rates down for infectious-disease serology requests like this one.

Practices also benefit from digital intake forms that capture travel history, presenting symptoms, and authorization numbers before the appointment. That information flows directly into the invoice workflow, so every serology claim is supported by the details an insurer needs at the point of submission.

• Invoice from the clinical record: Generate invoices linked to the referral and lab request, reducing the risk of a specimen or code mismatch between documentation and billing.
• Digital patient records: Store travel history, referral letters, and authorization references in one place to support insurer audit requests.
• Integrated payment processing: Pabau’s integrated payment processing handles self-pay and insurer-billed invoices within the same system.
• Multi-location support: Practices billing pathology tests across multiple sites can manage CCSD invoicing consistently without duplicating manual processes.

For practices managing broader compliance requirements across regulated private practice settings, Pabau’s documentation infrastructure also supports the audit trail that insurer reviews look for.

Conclusion

CCSD code 0527C bills a test that carries genuine clinical nuance. A positive Flavivirus IgG result confirms exposure to the flavivirus family, but the specimen type, the timing of the sample, and whether paired testing or neutralization confirmation followed all shape whether that result supports a specific diagnosis.

Getting the code and the specimen letter right is step one. Documenting the clinical reasoning behind the result is what gets the invoice paid without a query.

Pabau’s practice management platform helps UK private practices align their clinical documentation and invoicing workflows so every CCSD claim is supported by the records an insurer needs. To see how Pabau handles private billing documentation, book a demo with the team.

Continue your research

Need a walkthrough of another Chapter 34 pathology code? CCSD code 0537G covers the test description, insurer acceptance, and billing steps for that assay.

Looking for a primer on UK private practice billing workflows? Benefits of running a private practice outlines the operational and financial differences between NHS and private practice revenue cycles.

Curious how a simpler pathology code is billed? CCSD code 0080S walks through what the test covers and how to invoice it correctly.

Frequently Asked Questions